| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
,
PAUL C. MACDONALD and
EVAN R. SIMPSON
The Cecil H. and Ida Green Center for Reproductive Biology Sciences and the Departments of Obstetrics and Gynecology and Biochemistry, University of Texas Southwestern Medical School Dallas, Texas 75235
Address all correspondence and requests for reprints to: David Gal, M.D., Department of Obstetrics and Gynecology, The University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, Texas 75235.
The effect of progesterone on the regulation of 3- hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase activity by low density lipoprotein (LDL) was studied in eight gynecological cancer cell lines maintained in monolayer culture. In the absence of LDL and progesterone, the specific activity of HMG CoA reductase varied widely from one cell line to another (range, 200–2500 pmol mg microsomal protein–1 min–1). As in noncancerous cells, LDL suppressed the activity of HMG CoA reductase in all cell lines. Progesterone (40 JUM) attenuated or abolished the decrease in specific enzyme activity normally brought about by LDL. Progesterone, in the absence of LDL, stimulated HMG CoA reductase activity in some of these cell lines. Other steroids (cortisol and estradiol) had no effect on the specific activity of HMG CoA reductase. The mechanism by which progesterone stimulates HMG CoA reductase activity is not clear, but since progesterone receptors were not detectable in these cells a mechanism independent of the classic hormone receptor-mediated phenomenon is likely to be involved.
* This work was supported in part by USPHS Grant 1-P01-AG- 00306 and 1-R01-HD-13234.
Postdoctoral trainee supported in part by USPHS Training Grant 1-T32–07190.
Received November 24, 1980.
This article has been cited by other articles:
![]() |
Y. Suarez, C. Fernandez, D. Gomez-Coronado, A. J. Ferruelo, A. Davalos, J. Martinez-Botas, and M. A. Lasuncion Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin Cardiovasc Res, November 1, 2004; 64(2): 346 - 355. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |